Stay updated on Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial

Sign up to get notified when there's something new on the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    New help and guidance sections have been added, including How to Read a Study Record, Common Questions, and How to Join a Study. There is a recruitment status notice stating no participants are being sought, and the Intervention/Treatment header formatting was standardized with a revision update to v3.6.0 (replacing v3.5.5).
    Difference
    0.5%
    Check dated 2026-06-12T15:51:51.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page revision label was updated to v3.5.5, replacing v3.5.4. This reflects a new version of the page and is a metadata update rather than a change to the study data or content.
    Difference
    0.1%
    Check dated 2026-06-05T11:34:34.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page shows a new revision tag, v3.5.4, replacing the previous v3.5.3, indicating the study record page has been updated to a newer release.
    Difference
    0.1%
    Check dated 2026-05-15T02:19:39.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.5.3' has been added, replacing the previous 'Revision: v3.5.2'. This metadata update does not alter the study details, eligibility criteria, or any participant-facing information.
    Difference
    0.1%
    Check dated 2026-04-30T18:06:29.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The site revision was updated from v3.5.0 to v3.5.2. No visible changes to study details or navigation.
    Difference
    0.1%
    Check dated 2026-04-16T11:15:35.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Added the term 'Mucopolysaccharidosis, MPS-II' and removed 'Mucopolysaccharidosis type 2' from the study's glossary/keywords.
    Difference
    0.1%
    Check dated 2026-03-25T21:25:03.000Z thumbnail image

Stay in the know with updates to Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page.